Ellomay Capital Ltd. filed a Form 6-K on November 19, 2026, announcing that the Israel Securities Authority extended the term of the company's Israeli shelf prospectus by 12 months, until November 27, 2027.

Key Highlights

  • Extension granted: The Israel Securities Authority extended the shelf prospectus originally filed in November 2024 by 12 months.
  • New expiry date: The extended shelf prospectus is valid until November 27, 2027.
  • Securities covered: The shelf prospectus allows the company to offer and sell various securities in Israel, including debt and equity, at its discretion.
  • No decision made: According to the filing, the company "has not yet made any decision as to any offering of securities pursuant to the Shelf Prospectus, nor as to the scope, terms or timing of any such offering."
  • U.S. restriction: Securities offered under the shelf prospectus will not be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States or to U.S. Persons absent registration or an applicable exemption.
  • Israel-only offering: Any offering, if made, will be conducted only in Israel unless otherwise specified in a shelf offering report.

Ellomay Capital Gains Additional Year Under Israeli Shelf Prospectus

Ellomay Capital Ltd. (NYSE:ELLO), an Israeli company, disclosed via Form 6-K for the month of November 2026 that the Israel Securities Authority has extended the term of its Israeli shelf prospectus. The original shelf prospectus was filed in November 2024, and the extension adds 12 months to its validity, pushing the expiration date to November 27, 2027.

According to the filing, the shelf prospectus permits the company to raise funds from time to time through offerings of various securities, including both debt and equity instruments, in Israel. The company stated that any specific offering would be made pursuant to a shelf offering report describing the terms and details of the securities being offered. The filing emphasized that the company has made no decisions regarding any securities offering under this facility, and "there is no certainty that any such offering will be made."

The filing also noted that securities offered under the shelf prospectus, to the extent any offering occurs, will not be registered under the U.S. Securities Act of 1933. As a result, they may not be offered or sold in the United States or to U.S. Persons as defined under Regulation S, unless registration requirements are met or an applicable exemption applies. The report was signed by Ran Fridrich, Chief Executive Officer and Director, and was dated November 19, 2026.

What Was Disclosed

Ellomay Capital Ltd. reported that the Israel Securities Authority extended the company's Israeli shelf prospectus, originally filed in November 2024, by 12 months until November 27, 2027, allowing potential future securities offerings in Israel at the company's discretion.